Latest Market News

Orthocell posts record FY26 revenue growth driven by expanding US and international sales of its collagen medical devices, while investing ahead in manufacturing capacity and product pipeline.

BLS Pharmaceuticals (ASX: BLS) reported a standout FY26 with revenue surging 161% to $74.2 million and net profit more than tripling to $15.4 million, driven by expanded manufacturing and major international contracts including a $50 million German supply deal.

Microba Life Sciences delivered a mixed FY26, with overall revenue slipping 5.8% to $14.76 million and a statutory loss widening 38.7% to $20.7 million. The company’s strategic pivot to core microbiome testing paid off with a 92% surge in core testing revenue and record test volumes in Australia and the UK. Despite the headline loss, underlying loss improved 11% thanks to cost cuts and AI-driven efficiencies. Microba is gearing up for the October launch of its GI Navigator diagnostic and targeting cash flow break-even on a run-rate basis in calendar 2027.

Adslot Ltd swung to a $4.2 million profit in FY2026, buoyed by a $6 million non-cash gain from deconsolidating its troubled subsidiary. The company’s restructuring efforts trimmed costs by 28%, but revenue fell 10%.

SportsHero Limited reported a dramatic surge in revenue to AU$1.05 million for FY26, driven by new telco partnerships and the HeroPlay gaming platform launch, while losses increased 29% as the company ramped up marketing and development costs.

The Calmer Co. International Limited posted a record $8.1 million revenue for FY26, driven by retail and wholesale growth, yet recorded a $3.8 million net loss amid ongoing funding challenges and strategic investments.

Pengana Global Private Credit Trust (ASX: PCX) reported a solid FY26 with an 8.8% cash distribution yield and stable credit quality despite fair value pressures from widening credit spreads.

Eneco Refresh Limited has posted a 6.8% increase in revenue to $17.73 million for FY2026, alongside a remarkable 2072% jump in comprehensive profit after tax to $446,000, driven by operational improvements and resilience amid market volatility.

Maggie Beer Holdings reported a 60.8% reduction in net loss for FY26 to $9.5 million despite flat sales, driven by margin gains and cost cuts. The company appointed Chris Illman as Managing Director to lead its recovery and growth strategy.

Cadence Opportunities Fund (ASX: CDO) is offering eligible shareholders a chance to buy up to $30,000 of shares at a 3.5% discount to market price, following a 30.3% portfolio gain for FY26 and a 41% total shareholder return.

Nimy Resources reports metallurgical tests achieving 84% gallium and up to 95% rare earth extraction at its Mons Project Block 3, underpinning proprietary processing technology and feeding into a scoping study.

AMCIL posted a $6.9 million profit for FY2026 while its portfolio returned negative 10%, underperforming the ASX 200. The company cut dividends to 4.0 cents fully franked, reshuffled holdings, and welcomed Alison Gibson as new CEO.